Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company was founded in 1983 and is headquartered in Seattle, WA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Mark Austin | affiliate | Sep 12 '24 | Proposed Sale | 15.80 | 2,500 | 39,500 | | Sep 12 02:44 PM | Hunt Jonathan Robert | Chief Financial Officer | Jun 17 '24 | Buy | 9.81 | 1,800 | 17,667 | 35,971 | Jun 18 07:48 AM | Woods Lori A | Director | Jun 14 '24 | Buy | 10.90 | 4,587 | 49,990 | 159,985 | Jun 18 07:45 AM | Spoor Johan M. | CEO | Jun 13 '24 | Buy | 1.17 | 100,000 | 117,430 | 137,572 | Jun 13 05:19 PM | Woods Lori A | Director | Jun 03 '24 | Buy | 1.46 | 34,246 | 49,992 | 1,553,984 | Jun 04 04:02 PM | Hunt Jonathan Robert | Chief Financial Officer | May 31 '24 | Buy | 1.40 | 25,006 | 35,007 | 341,716 | Jun 03 04:05 PM | Williamson Robert F III | Director | May 31 '24 | Buy | 1.38 | 55,000 | 75,900 | 423,792 | Jun 03 04:01 PM | Williamson Robert F III | Director | May 29 '24 | Buy | 1.33 | 30,031 | 40,014 | 368,792 | May 30 04:05 PM | Austin Mark John | VP Finance/Prin Fin&Acct Offic | Apr 23 '24 | Option Exercise | 0.36 | 30,000 | 10,800 | 84,030 | Apr 24 04:35 PM | Lantheus Alpha Therapy, LLC | 10% Owner | Mar 06 '24 | Buy | 0.95 | 60,431,039 | 57,409,487 | 116,773,394 | Mar 08 11:24 AM | Williamson Robert F III | Director | Jan 30 '24 | Buy | 0.71 | 127,206 | 90,710 | 338,761 | Feb 01 04:53 PM | Williamson Robert F III | Director | Jan 26 '24 | Buy | 0.56 | 110,613 | 62,304 | 186,289 | Jan 30 04:57 PM | Williamson Robert F III | Director | Jan 29 '24 | Buy | 0.64 | 25,266 | 16,170 | 211,555 | Jan 30 04:57 PM | Puhlmann Markus | Chief Medical Officer | Jan 24 '24 | Buy | 0.50 | 280,000 | 139,888 | 1,375,425 | Jan 26 05:40 PM | Williamson Robert F III | Director | Jan 24 '24 | Buy | 0.49 | 29,862 | 14,632 | 53,542 | Jan 26 05:38 PM | Williamson Robert F III | Director | Jan 25 '24 | Buy | 0.49 | 22,134 | 10,846 | 75,676 | Jan 26 05:38 PM | Williamson Robert F III | Director | Dec 21 '23 | Buy | 0.33 | 3,663 | 1,203 | 3,663 | Dec 26 05:00 PM | Hunt Jonathan Robert | Chief Financial Officer | Dec 18 '23 | Buy | 0.26 | 125,000 | 32,338 | 316,710 | Dec 19 07:11 PM | Williamson Robert F III | Director | Dec 19 '23 | Buy | 0.32 | 13,680 | 4,378 | 23,680 | Dec 19 07:10 PM | Williamson Robert F III | Director | Dec 18 '23 | Buy | 0.26 | 10,000 | 2,600 | 10,000 | Dec 19 07:10 PM | Puhlmann Markus | Chief Medical Officer | Dec 19 '23 | Buy | 0.34 | 400,000 | 137,000 | 1,095,425 | Dec 19 07:09 PM | Puhlmann Markus | Chief Medical Officer | Dec 15 '23 | Buy | 0.27 | 135,006 | 36,276 | 635,006 | Dec 19 07:09 PM | Puhlmann Markus | Chief Medical Officer | Dec 18 '23 | Buy | 0.26 | 60,419 | 15,461 | 695,425 | Dec 19 07:09 PM | Woods Lori A | Director | Dec 15 '23 | Buy | 0.27 | 152,962 | 41,284 | 1,519,738 | Dec 18 04:16 PM | Woods Lori A | Director | Dec 14 '23 | Buy | 0.27 | 32,238 | 8,704 | 1,366,776 | Dec 18 04:16 PM |
|